Cite
HARVARD Citation
Isakoff, S. et al. (2017). A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. Future oncology. pp. 307-320. [Online].